Department of Surgery, Division of Neurosurgery, Toronto Western Hospital, University Health Network, WW 4-450, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.
Neurosurg Clin N Am. 2010 Apr;21(2):235-46. doi: 10.1016/j.nec.2009.10.014.
Aneurysmal subarachnoid hemorrhage (aSAH) is a neurosurgical catastrophe. It affects 33,000 patients in the United States annually and has a mortality rate of 50% to 60% at 30 days. Half of the survivors are dependent. Outcome is closely related to the level of consciousness at the time of presentation, global cerebral edema, subarachnoid blood load as seen on CT, and rehemorrhage. Age, hyperglycemia, and medical complications are associated with worse outcomes. The cost impact factor of this condition is high from a financial perspective as well as from a patient perspective. Care givers show increased morbidity when compared with the nonaffected community. Early aggressive treatment of good grade patients seems to provide the best outcome for this serious condition.
颅内动脉瘤性蛛网膜下腔出血(aSAH)是一种神经外科灾难。它每年影响美国 33000 名患者,30 天死亡率为 50%至 60%。一半的幸存者依赖他人。结果与发病时的意识水平、全脑水肿、CT 所见的蛛网膜下腔血液负荷以及再出血密切相关。年龄、高血糖和医疗并发症与更差的预后相关。从经济角度和患者角度来看,这种情况的成本影响因素都很高。与未受影响的社区相比,护理人员的发病率更高。对于这种严重情况,早期积极治疗良好分级的患者似乎提供了最佳的结果。